BACKGROUND AND PURPOSE: Lung epithelial cells express pattern recognition receptors, which react to bacteria. We have evaluated the effect of Gram-positive and Gram-negative bacteria on interleukin-8 (CXCL8) release from epithelial cells and the integrity of the epithelial barrier. EXPERIMENTAL APPROACH: Primary cultures of human airway epithelial cells and the epithelial cell line A549 were used, and CXCL8 release was measured after exposure to Gram-negative or Gram-positive bacteria. Epithelial barrier function was assessed in monolayer cultures of A549 cells. RESULTS: Gram-positive bacteria Staphylococcus aureus or Streptococcus pneumoniae, induced release of CXCL8 from human airway epithelial cells. These bacteria also disrupted barrier function in A549 cells, an effect mimicked by CXCL8 and blocked by specific binding antibodies to CXCL8. Gram-negative bacteria Escherichia coli or Pseudomonas aeruginosa induced greater release of CXCL8 than Gram-positive bacteria. However, Gram-negative bacteria did not affect epithelial barrier function directly, but prevented disruption induced by Gram-positive bacteria. These effects of Gram-negative bacteria on barrier function were mimicked by FK565, an agonist of the nucleotide-binding oligomerization domain 1 (NOD1) receptor, but not by the Toll-like receptor (TLR) 4 agonist bacterial lipopolysaccharide. Neither the Gram-negative bacteria nor FK565 blocked CXCL8 release. CONCLUSIONS: These data show differential functional responses induced by Gram-negative and Gram-positive bacteria in human lung epithelial cells. The NOD1 receptors may have a role in preventing disruption of the epithelial barrier in lung, during inflammatory states.
BACKGROUND AND PURPOSE: Lung epithelial cells express pattern recognition receptors, which react to bacteria. We have evaluated the effect of Gram-positive and Gram-negative bacteria on interleukin-8 (CXCL8) release from epithelial cells and the integrity of the epithelial barrier. EXPERIMENTAL APPROACH: Primary cultures of human airway epithelial cells and the epithelial cell line A549 were used, and CXCL8 release was measured after exposure to Gram-negative or Gram-positive bacteria. Epithelial barrier function was assessed in monolayer cultures of A549 cells. RESULTS: Gram-positive bacteria Staphylococcus aureus or Streptococcus pneumoniae, induced release of CXCL8 from human airway epithelial cells. These bacteria also disrupted barrier function in A549 cells, an effect mimicked by CXCL8 and blocked by specific binding antibodies to CXCL8. Gram-negative bacteria Escherichia coli or Pseudomonas aeruginosa induced greater release of CXCL8 than Gram-positive bacteria. However, Gram-negative bacteria did not affect epithelial barrier function directly, but prevented disruption induced by Gram-positive bacteria. These effects of Gram-negative bacteria on barrier function were mimicked by FK565, an agonist of the nucleotide-binding oligomerization domain 1 (NOD1) receptor, but not by the Toll-like receptor (TLR) 4 agonist bacterial lipopolysaccharide. Neither the Gram-negative bacteria nor FK565 blocked CXCL8 release. CONCLUSIONS: These data show differential functional responses induced by Gram-negative and Gram-positive bacteria in human lung epithelial cells. The NOD1 receptors may have a role in preventing disruption of the epithelial barrier in lung, during inflammatory states.
Authors: Dodanim Talavera; Aida M Castillo; M C Dominguez; Alejandro Escobar Gutierrez; Isaura Meza Journal: J Gen Virol Date: 2004-07 Impact factor: 3.891
Authors: Robert J Edwards; Graham W Taylor; Melissa Ferguson; Stephen Murray; Nigel Rendell; Amanda Wrigley; Zhonghu Bai; Joseph Boyle; Simon J Finney; Angus Jones; Hugh H Russell; Claire Turner; Jonathan Cohen; Lee Faulkner; Shiranee Sriskandan Journal: J Infect Dis Date: 2005-07-18 Impact factor: 5.226
Authors: Catherine M Greene; Tomás P Carroll; Stephen G J Smith; Clifford C Taggart; James Devaney; Siobhan Griffin; Shane J O'neill; Noel G McElvaney Journal: J Immunol Date: 2005-02-01 Impact factor: 5.422
Authors: Kasper Hoebe; Philippe Georgel; Sophie Rutschmann; Xin Du; Suzanne Mudd; Karine Crozat; Sosathya Sovath; Louis Shamel; Thomas Hartung; Ulrich Zähringer; Bruce Beutler Journal: Nature Date: 2005-02-03 Impact factor: 49.962
Authors: Rosario Jimenez; Elizabeth Belcher; Shiranee Sriskandan; Ruth Lucas; Shaun McMaster; Ivana Vojnovic; Timothy D Warner; Jane A Mitchell Journal: Proc Natl Acad Sci U S A Date: 2005-03-08 Impact factor: 11.205
Authors: Jane A Mitchell; Mark J Paul-Clark; Graham W Clarke; Shaun K McMaster; Neil Cartwright Journal: J Endocrinol Date: 2007-06 Impact factor: 4.286
Authors: Lynne Armstrong; Andrew R L Medford; Kay M Uppington; John Robertson; Ian R Witherden; Teresa D Tetley; Ann B Millar Journal: Am J Respir Cell Mol Biol Date: 2004-03-25 Impact factor: 6.914
Authors: Cristina Cigana; Laura Curcurù; Maria Rosaria Leone; Teresa Ieranò; Nicola Ivan Lorè; Irene Bianconi; Alba Silipo; Flora Cozzolino; Rosa Lanzetta; Antonio Molinaro; Maria Lina Bernardini; Alessandra Bragonzi Journal: PLoS One Date: 2009-12-23 Impact factor: 3.240
Authors: Lesley Berghuis; Khaled Taha Abdelaziz; Jodi Bierworth; Leanna Wyer; Gabriella Jacob; Niel A Karrow; Shayan Sharif; Mary Ellen Clark; Jeff L Caswell Journal: Vet Res Date: 2014-10-12 Impact factor: 3.683
Authors: Elyse Y Bissonnette; Jean-François Lauzon-Joset; Jason S Debley; Steven F Ziegler Journal: Front Immunol Date: 2020-10-15 Impact factor: 7.561